¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå ±Ô¸ð ºÐ¼® : ÀûÀÀ Áúȯº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2025-2035³â)
Global Hydroxychloroquine Market Size Study & Forecast, by Disease Indication and Distribution Channel, and Regional Forecasts 2025-2035
»óǰÄÚµå : 1755661
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,814,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,604,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ ¾à 11¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2035³âÀÇ ¿¹Ãø ±â°£ Áß 4.70%ÀÇ CAGR·Î °ß°íÇÏ°Ô È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀº ¿À·£ ¿ª»ç¸¦ °¡Áø Ç׸»¶ó¸®¾ÆÁ¦ÀÌÀÚ ¸é¿ªÁ¶ÀýÁ¦ÀÌÁö¸¸, ÃÖ±Ù ¸î ³â µ¿¾È ƯÈ÷ Àü ¼¼°è º¸°Ç ºñ»ó»çÅ¿¡ ´ëÇÑ ÀûÀÀÁõ ¿Ü »ç¿ëÀ¸·Î ÀÎÇØ ´Ù½Ã ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ È­ÇÕ¹°Àº ·ù¸¶Æ¼½º °üÀý¿° ¹× ·ù¸¶Æ¼½º °üÀý¿°°ú °°Àº ¸¸¼º ÀÚ°¡¸é¿ª ÁúȯÀÇ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ¿ë È¿À²¼º°ú ±¤¹üÀ§ÇÑ ¾à¸®ÇÐÀû ÇÁ·ÎÆÄÀÏÀº ´Ù¾çÇÑ ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ó¹æÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹°ú ¼±Áø±¹ ¸ðµÎ¿¡¼­ Áúº´ Á¶Àý Ä¡·á¿¡ ´ëÇÑ Àνİú Á¢±Ù¼ºÀÌ Çâ»óµÇ°í, ¸Å°³¼º Áúȯ°ú ÀÚ°¡¸é¿ªÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹Í »óȲ¿¡¼­ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀÇ ºÎȰÀº ÀϽÃÀûÀÎ ¼¼°è ¼ö¿ä ±ÞÁõ¿¡ ±â¿©ÇÏ¿© »ý»ê ¹× À¯Åë ÀÎÇÁ¶ó¸¦ °¡¼ÓÈ­Çß½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÌ Ç×¹ÙÀÌ·¯½ºÁ¦ÀÇ À¯¿ë¼º¿¡ ´ëÇØ ½ÅÁßÇÑ Åµµ¸¦ ÃëÇÏ´Â µ¿¾È, ÀÌ »ç°ÇÀº ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄýÀÌ ºñ»ó ´ëºñ ÆÄÀÌÇÁ¶óÀο¡ ÀûÀÀÇÒ ¼ö ÀÖ´Ù´Â °ÍÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù. ¶ÇÇÑ ¾ÆÇÁ¸®Ä«, ¾Æ½Ã¾Æ ¹× ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÀϺΠÁö¿ª¿¡¼­´Â ¸»¶ó¸®¾ÆÀÇ Áö¼ÓÀûÀÎ °¨¿° »ç·Ê°¡ °è¼ÓÇØ¼­ ±âÁؼ± ¼ö¿ä¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀº ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í ¾à¹°ÀÇ Ä¡·á ½ºÆåÆ®·³À» ³ÐÈ÷±â À§ÇØ ¼­¹æÇü Á¦Á¦ ¹× º´¿ë¿ä¹ý¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª Àå±â »ç¿ëÀº ½É°¢ÇÑ ¾È°úÀû ÇÕº´Áõ°ú ½ÉÇ÷°ü°è ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ°í, ÀϺΠÁö¿ª¿¡¼­´Â ¹«Á¦ÇÑ µµÀÔÀÌ Á¦ÇѵǾî ÀÖÀ¸¹Ç·Î ½ÃÀåÀº ¿©ÀüÈ÷ ºÎÀÛ¿ë¿¡ ´ëÇÑ ±ÔÁ¦¿¡ ´ëÇØ °í¹ÎÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªº°·Î »ìÆìº¸¸é, ºÏ¹Ì´Â ³ôÀº ÀÚ°¡¸é¿ªÁúȯ À¯º´·ü, ±¤¹üÀ§ÇÑ º¸Çè Àû¿ë, °­·ÂÇÑ R&D Áö¿øÀ¸·Î ÀÎÇØ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. À¯·´Àº ü°èÈ­µÈ ÀÓ»ó °¡À̵å¶óÀΰú ³ôÀº Ä¡·á ¼øÀÀµµ¿¡ ÈûÀÔ¾î ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ôÀº ¸»¶ó¸®¾Æ ¹ßº´·ü°ú Àεµ, Àεµ³×½Ã¾Æ µîÀÇ ±¹°¡¿¡¼­ ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­Çϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»óÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿Í Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«µµ ÁøÇà ÁßÀÎ ¸»¶ó¸®¾Æ ÅðÄ¡ ÇÁ·Î±×·¥°ú ·ù¸ÓƼÁò Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å« ±â¿©¸¦ ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹® ¹× ±¹°¡º° ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â ºÐ¼® ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀÎ ¹× °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ ¼¼ºÎ ºÎ¹®°ú ÇÏÀ§ ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå : ºÐ¼® ¹üÀ§¡¤¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå : ¿ªÇÐ ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : ÀûÀÀ Áúȯº°(2025-2035³â)

Á¦6Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : À¯Åë ä³Îº°(2025-2035³â)

Á¦7Àå ¼¼°èÀÇ ÇÏÀ̵å·Ï½ÃŬ·Î·ÎÄý ½ÃÀå ±Ô¸ð¡¤¿¹Ãø : Áö¿ªº°(2025-2035³â)

Á¦8Àå °æÀï Á¤º¸

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hydroxychloroquine Market is valued at approximately USD 1.12 billion in 2024 and is expected to expand at a robust CAGR of 4.70% throughout the forecast period from 2025 to 2035. Hydroxychloroquine, a time-tested antimalarial and immunomodulatory drug, has garnered renewed attention in recent years due to its off-label applications, particularly during global health emergencies. This compound plays a critical role in managing chronic autoimmune diseases such as rheumatoid arthritis and lupus erythematosus. Additionally, its cost-effectiveness and broad pharmacological profile have fueled its prescription across a diverse set of healthcare systems. The market's growth is largely underpinned by increasing prevalence of vector-borne diseases and autoimmune conditions, alongside rising awareness and accessibility of disease-modifying treatments in both developing and developed nations.

The resurgence of hydroxychloroquine during the COVID-19 pandemic has contributed to a temporary spike in global demand, accelerating its production and distribution infrastructure. While regulatory agencies remain cautious about its antiviral utility, this event showcased hydroxychloroquine's adaptability in emergency preparedness pipelines. Moreover, persistent cases of malaria in parts of Africa, Asia, and Latin America continue to secure a baseline demand. Pharmaceutical players are investing in extended-release formulations and combination therapies to improve patient compliance and broaden the drug's therapeutic spectrum. However, the market still grapples with regulatory scrutiny surrounding its side effects, as prolonged use may lead to serious ophthalmic and cardiovascular complications-limiting its unrestricted adoption in some regions.

From a regional perspective, North America represents a substantial share in the hydroxychloroquine market, fueled by the high incidence of autoimmune diseases, widespread insurance coverage, and strong R&D backing. Europe follows closely, buoyed by structured clinical guidelines and high treatment adherence rates. Meanwhile, the Asia Pacific region is expected to witness the fastest growth rate during the forecast period, owing to a high malaria burden and increasing government efforts to enhance healthcare infrastructure in countries like India and Indonesia. Latin America and the Middle East & Africa also contribute significantly due to ongoing malaria control programs and growing awareness of rheumatologic treatments.

Major market player included in this report are:

Global Hydroxychloroquine Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Disease Indication:

By Distribution Channel:

By Region:

Key Takeaways:

Table of Contents

Chapter 1. Global Hydroxychloroquine Market Report Scope & Methodology

Chapter 2. Executive Summary

Chapter 3. Global Hydroxychloroquine Market Forces Analysis

Chapter 4. Global Hydroxychloroquine Industry Analysis

Chapter 5. Global Hydroxychloroquine Market Size & Forecasts by Disease Indication 2025-2035

Chapter 6. Global Hydroxychloroquine Market Size & Forecasts by Distribution Channel 2025-2035

Chapter 7. Global Hydroxychloroquine Market Size & Forecasts by Region 2025-2035

Chapter 8. Competitive Intelligence

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â